Keurig Dr Pepper reports Q1 2026 results on April 30 with options traders signalling unusual bullishness — a stark contrast to a short book that has quietly been building.
The options setup is the most striking feature of the pre-earnings positioning. The put/call ratio has collapsed to 0.42, more than 2.5 standard deviations below its 20-day average of 0.62 — the most call-skewed reading in months, and close to the 52-week low of 0.21. That represents a sharp reversal from the defensive posture that held through most of March and early April, when the PCR ran consistently above 0.64. The shift coincides with a stock that has recovered 6.2% on the week to $28.15, clawing back ground after a 3.7% drop on Monday.
Short interest tells a more cautious story underneath the bullish options surface. Bears have added meaningfully into the print — short interest jumped 24.5% over the past month to 4.6% of the free float, with a further 6% single-day spike on April 24. That said, the borrow market shows no signs of stress. Cost to borrow has eased to just 0.41%, down 15% from a month ago. Utilization, at 8.2%, is essentially at its 52-week high of 8.4% — suggesting the lending market is nearly fully deployed — but the overall levels remain low enough that squeeze pressure is minimal heading into the release.
Analysts have been active on both sides in the past two weeks. Several bellwether names trimmed targets mid-April on tariff and macro concerns — JP Morgan cut from $36 to $32, Citi dropped from $37 to $32, and Barclays moved from $32 to $28. Then, following what appears to be early positive data flow, those same names reversed course: JP Morgan nudged its target back to $33, UBS lifted its Buy-rated target to $34, and Barclays added $2 back to reach $30. BNP Paribas upgraded outright from Underperform to Neutral. The consensus mean now sits at $33.25, implying roughly 18% upside from current levels. Bulls point to continued US coffee retail sales growth and resilient ready-to-drink momentum. Bears focus on pro-forma leverage of approximately 5.2x projected for year-end, brewer shipment declines of around 25% in Q3 2025, and a sharply reduced international organic sales growth forecast — particularly weakness in Mexico.
On the ownership side, Fidelity and Wellington both added materially in recent filings, with T. Rowe Price increasing its position by nearly 29 million shares as of March 31 — a notable vote of confidence from major active managers just ahead of the print. The last confirmed earnings reaction, from February, was a muted +0.4% on the day before a 7% five-day decline — a reminder that initial relief moves have not always held.
Wednesday's print is therefore a test of whether the recent analyst target re-ratings and the surge in call positioning reflect genuine fundamental improvement, or whether leverage concerns and soft international trends reassert themselves once the numbers are on the table.
See the live data behind this article on ORTEX.
Open KDP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
